These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8818008)

  • 1. Toxicity order of cholanic acids using an immobilised cell biosensor.
    Campanella L; Favero G; Mastrofini D; Tomassetti M
    J Pharm Biomed Anal; 1996 Jun; 14(8-10):1007-13. PubMed ID: 8818008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of bile acids on cell viability and DNA synthesis by rat hepatocytes in primary culture.
    Martinez-Diez MC; Serrano MA; Monte MJ; Marin JJ
    Biochim Biophys Acta; 2000 Feb; 1500(2):153-60. PubMed ID: 10657584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of negative ion thermospray liquid chromatography/tandem mass spectrometry for the determination of bile acids and their glycine conjugates.
    Eckers C; East PB; Haskins NJ
    Biol Mass Spectrom; 1991 Nov; 20(11):731-9. PubMed ID: 1799585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of conjugated dihydroxy bile acids by thin-layer chromatography.
    Touchstone JC; Levitt RE; Soloway RD; Levin SS
    J Chromatogr; 1979 Oct; 178(2):566-70. PubMed ID: 528661
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the binding of various bile acids and bile salts in vitro by several types of fiber.
    Story JA; Kritchevsky D
    J Nutr; 1976 Sep; 106(9):1292-4. PubMed ID: 956912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of pepsin activity by ursodeoxycholic acids and chenodeoxycholic acids.
    Eto T; Tompkins RK
    Am J Surg; 1985 Nov; 150(5):564-7. PubMed ID: 3933371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspects of the effect of bile salts on Candida albicans.
    Marshall SE; Marples BA; Salt WG; Stretton RJ
    J Med Vet Mycol; 1987 Oct; 25(5):307-18. PubMed ID: 3323449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholanic acids determined in commercial drugs by means of a new ISFET device.
    Campanella L; Battilotti M; Borraccino A; Colapicchioni C; Sammartino MP; Tomassetti M
    J Pharm Biomed Anal; 1993; 11(11-12):1207-14. PubMed ID: 8123735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1H and 13C NMR characterization and stereochemical assignments of bile acids in aqueous media.
    Ijare OB; Somashekar BS; Jadegoud Y; Nagana Gowda GA
    Lipids; 2005 Oct; 40(10):1031-41. PubMed ID: 16382575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, validation, and application of a single-tube radioimmunoassay for cholic and chenodeoxycholic conjugated bile acids in human serum.
    Roda A; Roda E; Aldini R; Festi D; Mazzella G; Sama C; Barbara L
    Clin Chem; 1977 Nov; 23(11):2107-13. PubMed ID: 912876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor.
    Ellis E; Axelson M; Abrahamsson A; Eggertsen G; Thörne A; Nowak G; Ericzon BG; Björkhem I; Einarsson C
    Hepatology; 2003 Oct; 38(4):930-8. PubMed ID: 14512880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acids in bile during long-term chenodeoxycholic acid treatment.
    Bremmelgaard A; Pedersen L
    Scand J Gastroenterol; 1976; 11(2):161-5. PubMed ID: 1265436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ursodeoxycholic acid in bile acid-mediated kidney fragment toxicity.
    Morgan WA; Kaler B; Bach PH
    Exp Toxicol Pathol; 1999 Jan; 51(1):35-9. PubMed ID: 10048711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of endotoxaemia in obstructive jaundice--a comparative study of bile salts.
    Pain JA; Bailey ME
    HPB Surg; 1988 Sep; 1(1):21-7. PubMed ID: 3153772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chenodeoxycholic acid (CDCA) versus ursodeoxycholic acid (UDCA): a comparison of their effects in pregnant rats.
    Celle G; Cavanna M; Bocchini R; Robbiano L; Dodero M; Volpi C; Dellepiane F; Cuneo-Crovari P; Scarvaglieri-Giuliano R; Sigari-Canu G
    Arch Int Pharmacodyn Ther; 1980 Jul; 246(1):149-58. PubMed ID: 7447544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-step analysis of individual conjugated bile acids in human bile using 1H NMR spectroscopy.
    Gowda GA; Ijare OB; Somashekar BS; Sharma A; Kapoor VK; Khetrapal CL
    Lipids; 2006 Jun; 41(6):591-603. PubMed ID: 16981437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.
    Mazzella G; Parini P; Bazzoli F; Villanova N; Festi D; Aldini R; Roda A; Cipolla A; Polimeni C; Tonelli D
    Dig Dis Sci; 1993 May; 38(5):896-902. PubMed ID: 8482188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition of platelet aggregation by bile salts.
    Baele G; Beke R; Barbier F
    Thromb Haemost; 1980 Oct; 44(2):62-4. PubMed ID: 7455992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.